[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636178":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":32,"centralContacts":37,"locations":47,"responsibleParty":64,"collaborators":31,"id":67,"slug":68,"hasResults":69,"nctId":70,"briefTitle":71,"officialTitle":72,"acronym":73,"eligibilityCriteria":74,"healthyVolunteers":69,"sex":75,"minAge":76,"maxAge":77,"enrollmentInfo":78,"targetDuration":31,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":89,"overallStatus":91,"whyStopped":31,"lastUpdateSubmitDate":92,"lastUpdatePostDateStruct":93,"startDateStruct":96,"completionDateStruct":98,"leadSponsor":100,"locationsCount":101},{"fullName":5,"class":6},"Assiut University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Group (D) DEX","ACTIVE_COMPARATOR","Dose: 0.2 mcg\u002Fkg IV in 10 mL saline, infused over 10 min pre-induction.",[13],"Drug: Dexamedomedine",{"label":15,"type":10,"description":16,"interventionNames":17},"Group (L) Lidocaine","Dose: 1.5 mg\u002Fkg IV (max 100 mg) in 10 ml saline over 1 min before induction.",[18],"Drug: Lidocaine (drug)",[20,27],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"DRUG","Dexamedomedine","IV 0.2 mic\u002F kg of dexmedetomidine will be diluted over 10 ml saline and given to the patient over 10 minutes before induction and assess the feasibility of classic LMA insertion",[9],[26],"DEX, Precedex",{"type":21,"name":28,"description":29,"armGroupLabels":30,"otherNames":31},"Lidocaine (drug)","IV 1.5 mg\u002Fkg of lidocaine will be diluted over 10 ml saline and given to the patient 1 minute before induction and assess the feasibility of classic LMA insertion",[15],null,[33],{"name":34,"affiliation":35,"role":36},"Abdelrahman Hamdy","Asyut University","PRINCIPAL_INVESTIGATOR",[38,43],{"name":39,"role":40,"phone":41,"phoneExt":31,"email":42},"Abdelrahman Hamdy, Lecturer","CONTACT","+201060989574","abdelrahmanhm89@gmail.com",{"name":44,"role":40,"phone":45,"phoneExt":46,"email":31},"Mohammed Adel, Lecturer","01050727722","+2",[48],{"facility":49,"status":31,"city":50,"state":51,"zip":52,"country":53,"countryCode":54,"cosmosGeoPoint":55,"geoPoint":60,"contacts":61},"Faculty of Medicine Assiut University","Asyut","Asyut Governorate","71621","Egypt","EG",{"type":56,"coordinates":57},"Point",[58,59],31.18368,27.18096,{"lat":59,"lon":58},[62],{"name":34,"role":40,"phone":63,"phoneExt":31,"email":42},"01060989574",{"type":36,"investigatorFullName":65,"investigatorTitle":66,"investigatorAffiliation":5,"oldNameTitle":31,"oldOrganization":31},"Abdelrahman Hamdy Mohammed","Lecturer of Anesthesia & ICU, Faculty of Medicine, Assiut University","100636178","laryngeal-mask-airways-are-supraglottic-devices-used-to-maintain-airway-patency-during-anesthesia-and-in-difficult-airways-iv-dexmedetomidine-improves-lma-insertion-success-and-decreases-coughing-while-iv-lidocaine-decreases-postoperative-cough-100636178",false,"NCT07562308","Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. IV Dexmedetomidine Improves LMA Insertion Success and Decreases Coughing, While IV Lidocaine Decreases Postoperative Cough.","Intravenous Dexmedetomidine Vs. Lidocaine for Laryngeal Mask Insertion Conditions In Pediatric Patients Undergoing Elective Surgeries, A Randomized Controlled Trial.","DEX LMA","Inclusion Criteria:\n\n* Parental\u002Fguardian consent.\n* Age 2-12 years\n* ASA physical status I-II.\n* Elective surgery requiring LMA (duration \\\u003C2 hours).\n\nExclusion Criteria:\n\n* Known airway anomalies (e.g., tonsillar hypertrophy, cleft palate).\n* Cardiovascular disease (bradycardia, arrhythmias).\n* Allergy to study drugs.\n* BMI \\>95th percentile.","ALL","2 Years","12 Years",{"count":79,"type":80},60,"ESTIMATED","INTERVENTIONAL",[83],"NA","Laryngeal Mask Airways Are Supraglottic Devices Used to Maintain Airway Patency During Anesthesia and in Difficult Airways. LMA may help in reducing postoperative pulmonary complications. IV Dexmedetomidine Improves LMA Insertion Success and Decreases trials number, While IV Lidocaine Decreases Postoperative Cough. This is a randomized interventional trial comparing both drugs. IV DEX will be compared vs IV lidocaine regarding the feasibility of insertion, number of trials, incidence of cough, postoperative pulmonary complications and hemodynamic profile.",[86,87,88],"Pediatric","Elective","Surgery in Early Childhood",[90],"Dexmedetomidine, Lidocaine, LMA, Pediatrics, Elective","NOT_YET_RECRUITING","2026-05-08",{"date":94,"type":95},"2026-05-12","ACTUAL",{"date":97,"type":80},"2026-05-01",{"date":99,"type":80},"2026-09-30",{"name":5,"class":6},1]